ALLMedicine™ Androgenetic Alopecia Center

Nov 11th, 2020 - Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia.|2020|Ho RS,|

Oct 31st, 2020 - Lichen planopilaris (LPP) is a scarring alopecia rarely described in men. To investigate the clinical and histopathologic features of LPP in men. We performed a retrospective cohort study of male patients with LPP seen at Mayo Clinic between 1992 ...

Oct 31st, 2020 - Androgenetic alopecia (AGA) is the most common cause of hair loss affecting both men and women. There are many conflicting results about the relationship between AGA and metabolic syndrome, (MetS) and the pathogenesis of the metabolic disorders in...

Oct 28th, 2020 - FDA-approved drugs for the most common type of hair loss, androgenetic alopecia (AGA), present many side effects and disadvantages. However, herbal compounds are characterized by patient compliance, fewer side effects, and several mechanisms of ac...

Oct 9th, 2020 - Finasteride is used to treat benign prostatic hyperplasia (BPH) and pattern hair loss (androgenetic alopecia or APA). The local administration of formulations with increased solubility and controlled release of finasteride are proposed using galla...

Jun 4th, 2018 - Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. In 2010, we published the first Japanese edition of guidelines for the diagnosis and treatment of MPHL. It achieved the origi...

Nov 27th, 2012 - Androgenetic alopecia (AGA), or pattern hair loss, is a common disorder in both Asian men and women. There are several guidelines for the treatment of AGA which are suitable for Caucasian patients; however, each of these has some limitations. Furt...

Dec 16th, 2011 - Guidelines for the management of androgenetic alopecia (2010).|2011|Tsuboi R,Itami S,Inui S,Ueki R,Katsuoka K,|therapeutic use,diagnosis,drug therapy,therapeutic use,transplantation,therapeutic use,therapeutic use,

Aug 27th, 2010 - Androgenetic alopecia (AGA) is the most common hair loss disorder, affecting both men and women. Due to the frequency and the often significant impairment of life perceived by the affected patients, competent advice, diagnosis and treatment is par...

Nov 30th, 2007 - Shiny hair with a smooth texture and clean-cut ends or tapered tips is generally perceived to be healthy. Hair texture and shine relate to hair surface properties, whereas the integrity of hair ends relates to the hair cortex. Hair can be straight...

Nov 11th, 2020 - Ongoing Concerns Regarding Finasteride for the Treatment of Male-Pattern Androgenetic Alopecia.|2020|Ho RS,|

Nov 11th, 2020 - Indications & Usage Section Finasteride tablets USP are indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY. Efficacy in bitemporal recession has not been established. Finasteride tablets USP are not indicated...

Oct 31st, 2020 - Lichen planopilaris (LPP) is a scarring alopecia rarely described in men. To investigate the clinical and histopathologic features of LPP in men. We performed a retrospective cohort study of male patients with LPP seen at Mayo Clinic between 1992 ...

Oct 31st, 2020 - Androgenetic alopecia (AGA) is the most common cause of hair loss affecting both men and women. There are many conflicting results about the relationship between AGA and metabolic syndrome, (MetS) and the pathogenesis of the metabolic disorders in...

Oct 28th, 2020 - FDA-approved drugs for the most common type of hair loss, androgenetic alopecia (AGA), present many side effects and disadvantages. However, herbal compounds are characterized by patient compliance, fewer side effects, and several mechanisms of ac...

Feb 20th, 2020 - LAHAINA, HAWAII – The list of nontraditional uses for botulinum toxin type A includes facial flushing, menopausal hot flashes, and androgenetic alopecia, Mark Rubin, MD, said at the Hawaii Dermatology Seminar provided by Global Academy for Medical.

Sep 17th, 2019 - Treatment with intradermal injections of autologous platelet-rich plasma (PRP) was associated with increased hair density in men and women with androgenetic alopecia, compared with placebo, according to a meta-analysis of seven studies. In the rep.

May 18th, 2019 - Gender-affirming hormone use was significantly associated with reports of androgenetic alopecia in transgender men, based on data from a survey of 991 individuals. Given the importance of hair in body image and gender identity, hair concerns are i.

May 18th, 2019 - Gender-affirming hormone use was significantly associated with reports of androgenetic alopecia in transgender men, based on data from a survey of 991 individuals. Given the importance of hair in body image and gender identity, hair concerns are i.

Jan 20th, 2019 - Dermatology presents a host of uses for PRP. In addition to application after microneedling or resurfacing and injectable aesthetic uses, PRP can also be used to treat melasma, acne scarring, and androgenetic alopecia.